These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

141 related items for PubMed ID: 7762847

  • 1. Reversal of residual neuromuscular block with neostigmine at one to four hours after a single intubating dose of vecuronium.
    Caldwell JE.
    Anesth Analg; 1995 Jun; 80(6):1168-74. PubMed ID: 7762847
    [Abstract] [Full Text] [Related]

  • 2. Time to peak effect of neostigmine at antagonism of atracurium- or vecuronium-induced neuromuscular block.
    Kirkegaard-Nielsen H, Helbo-Hansen HS, Lindholm P, Severinsen IK, Bülow K.
    J Clin Anesth; 1995 Dec; 7(8):635-9. PubMed ID: 8747561
    [Abstract] [Full Text] [Related]

  • 3. Conditions to optimise the reversal action of neostigmine upon a vecuronium-induced neuromuscular block.
    Baurain MJ, Dernovoi BS, D'Hollander AA, Hennart DA, Cantraine FR.
    Acta Anaesthesiol Scand; 1996 May; 40(5):574-8. PubMed ID: 8792887
    [Abstract] [Full Text] [Related]

  • 4. Inadequate antagonism of vecuronium-induced neuromuscular block by neostigmine during sevoflurane or isoflurane anesthesia.
    Morita T, Tsukagoshi H, Sugaya T, Saito S, Sato H, Fujita T.
    Anesth Analg; 1995 Jun; 80(6):1175-80. PubMed ID: 7762848
    [Abstract] [Full Text] [Related]

  • 5. Antagonism of moderate degrees of vecuronium-induced neuromuscular block by small doses of neostigmine.
    Johnson RA, Harper NJ.
    Br J Anaesth; 1989 May; 62(5):483-7. PubMed ID: 2567178
    [Abstract] [Full Text] [Related]

  • 6. Neostigmine reversal of vecuronium neuromuscular block and the influence of renal failure.
    Dhonneur G, Rebaine C, Slavov V, Ruggier R, De Chaubry V, Duvaldestin P.
    Anesth Analg; 1996 Jan; 82(1):134-8. PubMed ID: 8712389
    [Abstract] [Full Text] [Related]

  • 7. Speed of reversal of vecuronium neuromuscular block with different doses of neostigmine in anesthetized dogs.
    Martin-Flores M, Lorenzutti AM, Litterio NJ, Rossetti VL, Zarazaga MP, Bonetto CC, Aguirre GE.
    Vet Anaesth Analg; 2017 Jan; 44(1):28-34. PubMed ID: 27258375
    [Abstract] [Full Text] [Related]

  • 8. Can early administration of neostigmine, in single or repeated doses, alter the course of neuromuscular recovery from a vecuronium-induced neuromuscular blockade?
    Magorian TT, Lynam DP, Caldwell JE, Miller RD.
    Anesthesiology; 1990 Sep; 73(3):410-4. PubMed ID: 1975484
    [Abstract] [Full Text] [Related]

  • 9. Optimum time for neostigmine administration to antagonize vecuronium-induced neuromuscular blockade.
    Kirkegaard-Nielsen H, Toft P, Severinsen IK, May O.
    Eur J Anaesthesiol; 1995 Nov; 12(6):585-9. PubMed ID: 8665881
    [Abstract] [Full Text] [Related]

  • 10. Neuromuscular effects of vecuronium and neostigmine in Montreal and Paris.
    Salib Y, Frossard J, Plaud B, Debaene B, Meistelman C, Donati F.
    Can J Anaesth; 1994 Oct; 41(10):908-12. PubMed ID: 8001209
    [Abstract] [Full Text] [Related]

  • 11. Recovery from vecuronium neuromuscular blockade following neostigmine administration in infants, children, and adults during halothane anesthesia.
    Debaene B, Meistelman C, d'Hollander A.
    Anesthesiology; 1989 Dec; 71(6):840-4. PubMed ID: 2574016
    [Abstract] [Full Text] [Related]

  • 12. Factors affecting neostigmine reversal of vecuronium block during sevoflurane anaesthesia.
    Morita T, Kurosaki D, Tsukagoshi H, Shimada H, Sato H, Goto F.
    Anaesthesia; 1997 Jun; 52(6):538-43. PubMed ID: 9203879
    [Abstract] [Full Text] [Related]

  • 13. Required dose of sugammadex or neostigmine for reversal of vecuronium-induced shallow residual neuromuscular block at a train-of-four ratio of 0.3.
    He J, He H, Li X, Sun M, Lai Z, Xu B.
    Clin Transl Sci; 2022 Jan; 15(1):234-243. PubMed ID: 34435439
    [Abstract] [Full Text] [Related]

  • 14. [Effects of halothane and sevoflurane on reversal of neuromuscular blockade induced by vecuronium in man].
    Izawa H, Takeda J, Fukushima K.
    Masui; 1997 Feb; 46(2):177-83. PubMed ID: 9071099
    [Abstract] [Full Text] [Related]

  • 15. Sugammadex provides faster reversal of vecuronium-induced neuromuscular blockade compared with neostigmine: a multicenter, randomized, controlled trial.
    Khuenl-Brady KS, Wattwil M, Vanacker BF, Lora-Tamayo JI, Rietbergen H, Alvarez-Gómez JA.
    Anesth Analg; 2010 Jan 01; 110(1):64-73. PubMed ID: 19713265
    [Abstract] [Full Text] [Related]

  • 16. Effects of residual concentrations of isoflurane on the reversal of vecuronium-induced neuromuscular blockade.
    Baurain MJ, d'Hollander AA, Melot C, Dernovoi BS, Barvais L.
    Anesthesiology; 1991 Mar 01; 74(3):474-8. PubMed ID: 1672059
    [Abstract] [Full Text] [Related]

  • 17. Use of neostigmine in the antagonism of residual neuromuscular blockade produced by vecuronium.
    Jones JE, Hunter JM, Utting JE.
    Br J Anaesth; 1987 Nov 01; 59(11):1454-8. PubMed ID: 2891365
    [Abstract] [Full Text] [Related]

  • 18. A comparison of vecuronium by continuous infusion with either isoflurane or fentanyl-nitrous oxide anesthesia.
    Quill TJ, Glass PS.
    J Clin Anesth; 1989 Nov 01; 1(4):243-7. PubMed ID: 2576377
    [Abstract] [Full Text] [Related]

  • 19. Dose-response relationships for neostigmine antagonism of rocuronium-induced neuromuscular block in children and adults.
    Abdulatif M, Mowafi H, al-Ghamdi A, el-Sanabary M.
    Br J Anaesth; 1996 Dec 01; 77(6):710-5. PubMed ID: 9014620
    [Abstract] [Full Text] [Related]

  • 20. Reversal of vecuronium with neostigmine: a comparison between male and female patients.
    Saitoh Y, Aoki K, Okazaki M, Hirama T, Isosu T, Murakawa M.
    Fukushima J Med Sci; 2009 Dec 01; 55(2):61-70. PubMed ID: 20608096
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.